#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Treatment of Asthma and COPD

We recommend PL_doktor_studie_starsi

Profil účinku aklidinium-bromidu ve srovnání s glykopyrronium-bromidem

29. 3. 2021 Source: Treatment of Asthma and COPD

Studie španělských autorů zkoumala v podmínkách in vitro a in vivo profily 2 dlouhodobě působících antagonistů muskarinových receptorů (LAMA), aklidinium-bromidu a glykopyrronium-bromidu.

the GOLD strategy

Current Approaches to COPD Therapy According to GOLD Recommendations and in the Conditions of Czech Practice

Chronic Obstructive Pulmonary Disease (COPD) represents a significant global cause of morbidity and…
15. 11. 2022 Source: Treatment of Asthma and COPD
plicní rehabilitace

Impact of Rehabilitation on the Health of Patients with COPD

According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), pulmonary…
15. 11. 2022 Source: Treatment of Asthma and COPD

Articles on this topic
chronické obstrukční plicní nemoci_dýchání

Current Findings on Fixed Combination Aclidinium/Formoterol in COPD Therapy

The fixed inhalation combination of aclidinium/formoterol represents a combination of a…
30. 8. 2022 Source: Treatment of Asthma and COPD
CHOPN_lékař_pacient

Overview of the Efficacy of the Fixed Combination Aclidinium-Bromide/Formoterol-Fumarate in the Maintenance Treatment of COPD

Fixed combination inhalation medications have become the cornerstone of pharmacotherapy for…
30. 8. 2022 Source: Treatment of Asthma and COPD

Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#